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Laparoscopic renal biopsy.
Background. Renal biopsy continues to be a pivotal tool and
frequently indispensable diagnostic procedure in the clinical
assessment of proteinuria and or unexplained renal disease.
Laparoscopic renal biopsy has recently been reported as an
alternative to open renal biopsy.
Methods. Thirty-two patients who had proteinuria and/or renal
insufficiency underwent laparoscopic renal biopsy at our center.
The indications for biopsy included failed percutaneous biopsy
(N 5 3), morbid obesity (14), solitary kidney (5), chronic antico-
agulation/coagulopathy (6), religious consideration (refusal of
potential blood transfusion) (2), multiple bilateral renal cysts and
body habitus (1 case each). The kidney was approached via a
laparoscopic retroperitoneal route (retroperitoneoscopy) using a
two port technique. The lower pole of the kidney was localized
using blunt dissection, laparoscopic cup biopsies were performed,
and hemostasis was achieved using standard techniques.
Results. All biopsies were successfully completed laparoscopi-
cally with sufficient tissue obtained for histopathological diagnosis
in all cases. Mean estimated blood loss was 25.9 ml (range 5 to
100). None of the patients required parenteral narcotics during
the perioperative period. Operative time ranged from 0.8 to 3.0
hours (mean 1.5). Mean hospital stay was 1.7 days (range 0 to 7).
Sixteen patients were treated as outpatients. Patients returned to
normal activity at a mean of 1.7 weeks (range 0.3 to 3.0)
postoperatively. In one patient, the spleen was inadvertently
biopsied without consequence. An additional patient developed a
postoperative 300 cc perinephric hematoma that resolved without
the need for intervention. One postoperative mortality occurred
on postoperative day seven secondary to a perforated peptic ulcer
in a patient undergoing high-dose steroid therapy for lupus
nephritis.
Conclusion. Laparoscopic renal biopsy is a safe, reliable, mini-
mally invasive alternative to open renal biopsy for patients in
whom a closed percutaneous approach is either a relative or
absolute contraindication, which can be performed on an outpa-
tient basis.
Renal biopsy continues to be a pivotal tool and fre-
quently indispensable diagnostic procedure in the clinical
assessment of microscopic hematuria and proteinuria of
glomerular origin and/or unexplained renal disease [1–3].
Closed percutaneous biopsy, currently the standard ap-
proach, has proven to be a safe procedure when performed
by experienced hands in properly selected patients [2, 3].
Over time, the contraindications to percutaneous needle
biopsy of the kidney have decreased with the advent of
reliable, non-invasive imaging techniques and the develop-
ment of adequate protocols for patient monitoring during
the early post-biopsy period [4]. The development of small
caliber biopsy needles has also contributed to the increased
safety of this technique.
With such improvement in safety and reliability, several
clinical conditions that were until recently considered ab-
solute contraindications for percutaneous biopsy (for ex-
ample, solitary kidney and morbid obesity) are now consid-
ered to be relative contraindications [5]. However, there
still are some patients for whom a percutaneous approach
is risky with the only remaining option being a renal biopsy
under direct vision (such as mandatory chronic anticoagu-
lation and bleeding diathesis). Renal biopsy under direct
vision can be performed through an open incision or
laparoscopically via a transperitoneal [6, 7] or retroperito-
neal approach [8, 9]. These methods of biopsy are advan-
tageous in that the kidney is positively identified and that
biopsy and hemostasis are achieved under direct vision.
Although laparoscopic renal biopsy has been previously
reported, the number of cases is small [6–9]. We describe
the technique and report our experience in thirty-two




Table 1 shows the pertinent demographic and clinical
data of the cohort studied. Thirty-two patients who had
abnormal proteinuria of .150 mg/24 hr (31 cases) and or
renal insufficiency, defined a serum creatinine of . 1.5
mg/dl (18 cases) were referred for a laparoscopic renal
Key words: diagnostic procedure, closed percutaneous biopsy, complica-
tions of biopsy, transperitoneal biopsy approach, retroperitoneal biopsy
approach.
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biopsy. All patients had undergone a full evaluation by a
nephrologist beforehand. Twenty-nine patients were felt to
be unsuitable candidates for a percutaneous renal biopsy
due to morbid obesity, a solitary kidney, religious reasons
(that is, Jehovah’s Witness faith), or chronic anticoagula-
tion/coagulopathy. The remaining three patients had failed
previous attempts at percutaneous biopsy under ultrasound
guidance due to high kidneys that were not accessible from
below the rib cage, in one case, and a non-cooperative
patient in two cases.
Twenty-one women and 11 men underwent laparoscopic
renal biopsy. Mean patient age was 45.22 years (range, 3 to
79). Proteinuria ranged between 0.7 to 15.0 g/24 hr among
the 31 patients who demonstrated proteinuria within an
abnormal range. Body weight ranged from 60 to 180 kg.
Average serum creatinine was 2.99 mg/dl (range, 0.6 to
18.9). Of the 14 patients biopsied due to morbid obesity
alone, the mean body mass index (BMI) was 57.55 kg/m2
(range 40.1 to 62.6). Of note, in at least five of these
patients either failed biopsy (that is, no tissue) or the
kidney could not be visualized on ultrasound to perform a
percutaneous biopsy. The mean height and weight of these
14 patients was 1.65 m (range 1.48 to 1.83) and 140 kg
(range 100 to 180), respectively. Morbid obesity is consid-
ered ASA (American Society of Anesthesia) physical status
class 3. Of the entire group, two patients were ASA class 1,
18 were ASA class 2, 11 were ASA class 3 and one was ASA
class 4. The indications for pursuing a laparoscopic ap-
proach are listed in Table 2.
Operative technique
The biopsy was performed with the patient under general
anesthesia in the lateral decubitus position. A two port
technique was used via a retroperitoneal route: a 10 mm
laparoscopic port was placed above the iliac crest in the
posterior axillary line and a 5 mm port was placed at the
same level at the anterior axillary line. In morbidly obese
patients, the initial trocar was placed under direct vision
Table 2. Indications for laparoscopic biopsy




Religious faith (Jehovah’s Witness) 2
Multiple bilateral renal cystsa 1
Body habitus (cerebral palsy) 1
a Not hereditary polycystic kidney.
Table 1. Patient demographics








mm Hg Indication for lap bx
BMI
kg/m2
1 RH M 51 1.1 14.0 140/80 Chronic anticoagulation
2 JR F 43 0.8 5.5 120/90 Morbid obesity 47.7
3 KP F 23 1.4 7.3 110/90 Jehovah’s Witness
4 LM F 37 0.6 2.7 140/90 Morbid obesity 57.3
5 JS M 59 2.2 7.2 170/85 Chronic anticoagulation
6 DT F 65 1.2 5.6 142/84 Morbid obesity 46.1
7 RB M 37 1.8 1.1 140/70 Solitary kidney
8 VD F 49 2.1 1.8 150/70 Failed percutaneous bx
9 SB F 54 1.1 1.4 150/80 Body habitus (cerebral palsy)
10 VH F 79 4.9 2.0 148/60 Morbid obesity 40.1
11 FH F 55 3.9 3.5 131/67 Failed percutaneous bx
12 MA F 55 0.7 4.0 150/70 Solitary kidney/obesity 38.7
13 JH F 35 0.6 2.0 150/75 Jehovah’s Witness/obesity 59.9
14 VS M 61 3.4 ,0.15 140/80 Solitary kidney
15 NJ F 17 2.4 1.6 115/80 Morbid obesity 53.1
16 CT F 46 1.3 2.0 130/70 Morbid obesity 61.5
17 PW F 26 2.5 1.5 126/84 Morbid obesity 43.3
18 LF M 56 2.3 1.1 130/80 Chronic anticoagulation
19 MR M 31 18.9 0.7 140/90 Morbid obesity 53.7
20 MA F 51 1.9 1.0 132/82 Multiple bilateral renal cysts
21 TH F 21 1.0 5.7 148/90 Failed percutaneous bx
22 EW F 65 2.1 2.0 150/80 Solitary kidney
23 JS M 62 2.0 1.8 140/80 Char. anticoagulation 43.4
24 SP F 29 0.9 0.7 130/76 Morbid obesity 55.9
25 JH F 60 2.6 0.9 130/86 Morbid obesity 59.9
26 MW M 40 12.0 1.0 160/90 Morbid obesity 62.6
27 ME F 55 8.2 15.0 170/90 Morbid obesity 62.4
28 MK F 69 8.7 3.1 173/97 Coagulopathy
29 CW M 41 1.8 1.7 120/80 Morbid obesity 43.8
30 BD M 3 1.2 1.1 110/60 Solitary kidney
31 TB M 16 1.1 0.8 140/90 Coagulopathy
32 CB F 28 0.9 4.2 145/98 Morbid obesity 59.2
Abbreviations are: SCr, serum creatinine; BP, blood pressure; lap bx, laparoscopic biopsy; BMI, body mass index.
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using the Visiport device (Auto Suture; US Surgical Cor-
poration, Norwalk, CT, USA). In all other patients, a
pneumoretroperitoneum was created prior to initial trocar
placement as previously described [10]. Minimal blunt
dissection through retroperitoneal fat was performed in
order to expose the lower pole of the kidney. Laparoscopic
cup biopsy forceps were used to take multiple superficial
cortical biopsies. The presence of adequate renal tissue in
the biopsy specimen was confirmed on frozen section or
touch preparation. The biopsy site was fulgurated with an
argon beam coagulator and a sheet of oxidized cellulose
(Surgicel; Johnson and Johnson, Arlington, TX, USA) was
applied. After proper revision of the biopsy sites to make
sure hemostasis was succesfully accomplished, the gas was
evacuated and the skin was closed with an absorbable
suture. Patients were transfered to a recovery room, and
once awake and alert were allowed to resume full activity.
RESULTS
All 32 laparoscopic renal biopsies were successfully
performed with sufficient tissue obtained for histopatholog-
ical diagnosis in all cases. Diagnoses based on light and
electron microscopy and immunohistochemistry are listed
in Table 3. The operative time ranged from 0.8 to 3.0 hours
(mean 1.5). Mean estimated blood loss was 25.9 cc (range,
5 to 100).
Mean hospital stay was 1.7 days (range 0 to 7). None of
the patients required parenteral narcotics in the perioper-
ative period. No patient had gross hematuria postopera-
tively. Sixteen of the 32 patients (50%) undergoing laparo-
scopic renal biopsy were discharged on the day of the
procedure. Six additional patients were discharged follow-
ing an overnight stay. Prolonged hospitalization (.2 days)
was necessary in 8 patients for reasons unrelated to renal
biopsy: to resume anticoagulation in 3, to treat acute renal
failure in 4, and for pulse steroid treatment of severe lupus
nephritis in 1. Patients returned to normal activity at a
mean of 1.7 weeks (range 0.3 to 3.0) following surgery.
In one patient, the spleen was biopsied inadvertently.
This was recognized immediately, hemostasis was achieved
without difficulty, and the procedure was completed with-
out further complication. There were otherwise no intra-
operative complications. One patient with a coagulopaty
had persistent flank pain following the biopsy. Computer
tomography imaging demonstrated a 300 cc perinephric
hematoma that resolved without the need for surgical
intervention. Another patient underwent an uneventful
biopsy and was diagnosed with lupus nephritis. High-dose
steroid therapy was instituted on postoperative day 2. She
died one week later due to a perforated gastric ulcer that
was unrelated to the renal biopsy, she was a Jehova’s
witness and refused blood transfusions.
DISCUSSION
Histological evaluation of renal tissue is useful in the
evaluation and management of medical renal disease.
Histopathologic diagnosis often provides valuable informa-
tion in determining prognosis and guiding therapy [1–3].
General indications for renal biopsy include renal failure/
insufficiency of unknown etiology, nephrotic syndrome,
proteinuria, and systemic diseases with suspected renal
involvement such as systemic lupus erythematosus (SLE)
[1–3]. Although several methods are available, percutane-
ous renal biopsy is the most common method of sampling
renal tissue because it is reliable, minimally invasive, and
can be performed under local anesthesia [2, 3].
Unfortunately, not all patients in whom a percutaneous
approach is used are successfully biopsied, with as many as
5 to 20% of the cases yielding inadequate tissue for
histopathology diagnosis [11]. Difficulty in localizing and
accurately biopsying the kidney may be encountered when
the kidney is small or high up in the renal fossae, or when
the patient is extremely obese, uncooperative or has an
abnormal body habitus, such as in one of our cases in whom
a satisfactory position could not be established due to
musculoskeletal flexion-contractures due to cerebral palsy.
Relative contraindications to percutaneous renal biopsy
include previous failed attempts at percutaneous biopsy,
presence of a renal artery aneurysm, extremely obese or
uncooperative patients, uncontrolled hypertension, coagu-
lopathy, patients of the Jehovah’s Witness faith, and kid-
neys that are ectopic, small or solitary [2, 12]. In these
patients, a renal biopsy under direct vision may be pre-
ferred. In the past, these patients would have undergone
open renal biopsy with the associated risk for significant
postoperative morbidity. With advances in endoscopic in-
strumentation, however, the development of laparoscopic
renal biopsy now provides a minimally invasive alternative
to open renal biopsy. Although surgical approaches require
general anesthesia, their advantage is that the kidney is
identified, biopsied, and hemostasis is achieved under
direct vision in a controlled fashion. This is particularly
useful for patients requiring chronic anticoagulation, espe-
cially for those in whom prolonged withdrawal of therapy
such as it is required when a closed percutaneous approach
is used, would be risky.
Using an entirely extraperitoneal (retroperitoneal) endo-
scopic technique, we were able to obtain sufficient renal
tissue for pathological diagnosis in all cases (100%, 32 of
32). No severe bleeding complications requiring further
Table 3. Histopathologic diagnosis based on laparoscopic renal biopsy
Membranous glomerulonephritis 4
Glomerulosclerosis and focal segmental glomerulosclerosis 11






Gimenez et al: Laparoscopic renal biopsy 527
intervention or hematuria occurred in any of our patients
and none of our patients required blood transfusion. The
latter has made this technique particularly appealing to
patients of the Jehova’s witness faith. The high success rate
and lack of bleeding complications mirrors several modern
large open renal biopsy series [13–15]. In contrast, the
incidence of bleeding complications was found to be 5.0%
in a contemporary percutaneous renal biopsy series [11].
Other minimally invasive methods have been described
to obtain renal tissue. Leal reported using a transurethral
approach whereby a catheter is passed up via the ureter and
into the renal pelvis to obtain a transpelvic specimen in one
patient with renal disease [16]. To date further reports with
this technique are lacking. Mal and associates reported 200
cases in which a transjugular approach was used to do a
renal biopsy [17]. These were performed by a radiologist
under fluoroscopic guidance. However, sufficient tissue for
diagnosis was obtained only in 83% of the patients with 2%
of the total cases developing significant post-procedure
bleeding that required a blood transfusion. We feel that our
technique reduces the risk of hemorrhage, hematuria, and
the development of arteriovenous malformations as com-
pared to the percutaneous and transvenous approaches.
Hemostasis is an integral and important part of the proce-
dure that is always confirmed under direct vision. More-
over, the cup biopsy forceps used in the procedure takes
generous superficial cortical specimens without injuring the
deeper underlying central vessels or collecting system,
thereby decreasing the risk of AV malformations and
procuring always with adequate glomerular sample sizes.
This is in contrast to the needles used in the percutaneous
approach, which sometimes will yield samples containing
only medullary tissue, and at worst can potentially traverse
the hilum of the kidney and injure the collecting system or
large segmental vessels.
Three complications occurred in our series. In one
patient, the spleen was inadvertently biopsied. This was
recognized intraoperatively and confirmed on frozen sec-
tion. Splenic hemostasis was achieved without difficulty and
the kidney was identified and biopsied without difficulty
prior to completion of the procedure. The patient was
discharged from the hospital within 24 hours and had an
uncomplicated postoperative course. A second patient with
a coagulopathy bled postoperatively approximately 300 cc
into the perinephric space even though intraoperative
blood loss was minimal and adequate hemostasis was
achieved. The bleed ceased spontaneously and no further
intervention was necessary. Another patient underwent an
uneventful laparoscopic left renal biopsy. Because prelim-
inary pathological evaluation revealed severe lupus nephri-
tis, the patient was started on high-dose parenteral steroid
therapy on postoperative day 2. On postoperative day 5 the
patient developed acute abdominal pain and tenderness
and a perforated gastroduodenal ulcer was suspected.
Unfortunately, after refusing surgical intervention on reli-
gious grounds, she died on postoperative day 7. Autopsy
confirmed the presence of a perforated gastric ulcer, which
was unrelated to her laparoscopic renal biopsy.
Because laparoscopic renal biopsy is minimally invasive,
it offers several advantages over open renal biopsy. First,
our technique can be performed on an outpatient basis.
Sixteen patients were discharged on the day of surgery with
an additional 6 discharged after an overnight stay. Pro-
longed hospitalization (.2 days) was required to treat
concomitant medical problems unrelated to the biopsy
procedure itself in 8 (25%) of our cases, but these patients
would otherwise have been discharged shortly following the
procedure as well. The patients returned to full activity at a
mean of 1.7 weeks following surgery in this series. In obese
patients who have comorbid conditions such as diabetes
mellitus, the risk of wound infection is significant, particu-
larly for patients undergoing open renal biospy. In contrast,
both incisions with our technique are ,1 cm, minimizing
the possibility of wound complications. In fact, none of the
patients developed wound complications in our series.
The primary disadvantage of the laparoscopic approach
is that it is an operative procedure and therefore, more
invasive than the closed percutaneous approach. Surgery is
associated with definite risks of significant morbidity and
mortality. However, in modern series examining these risks
in patients classified as ASA 2 or 3 significant morbidity is
0.08% and mortality is 0.007% [18]. Moreover, surgery is
associated with costs (such as surgical fees, operating
charges, equipment costs, etc.) that make it more expensive
than a percutaneous approach.
Conclusion
Although percutaneous renal biopsy remains the stan-
dard approach, biopsy under direct vision may be safer and
more reliable in a subset of patients in whom the closed
percutaneous approach is contraindicated, technically un-
succesful or risky. This study suggests that laparoscopic
renal biopsy is a safe, reliable (100% success), and a
minimally invasive alternative to open renal biopsy, even in
the morbidly obese patient. This procedure can be rou-
tinely performed on an outpatient basis unless treatment of
a concomitant medical problem is warranted. Minimal
hospitalization requirement following laparoscopic biopsy
is an additional timely advantage over open renal biopsy in
the current climate of cost containment.
Reprint requests to Luis F. Gimenez, M.D., Department of Nephrology,
Johns Hopkins Hospital, Suite 958, 720 Rutland Avenue, Baltimore, Mary-
land 21205, USA.
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